Chris B. Russell
BioMarin (United States)(US)
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Asthma and respiratory diseases, Dermatology and Skin Diseases, Virus-based gene therapy research, Hemophilia Treatment and Research
Most-Cited Works
- → Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis(2012)925 cited
- → The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses(2013)516 cited
- → The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings(2012)453 cited
- → A prospective phase III, randomized, double‐blind, placebo‐controlled study of brodalumab in patients with moderate‐to‐severe plaque psoriasis(2016)450 cited
- → Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A(2020)446 cited
- → A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Disease(2016)364 cited
- → Chromosomal transformation of Escherichia coli recD strains with linearized plasmids(1989)168 cited
- → Gene Expression Profiles Normalized in Psoriatic Skin by Treatment with Brodalumab, a Human Anti–IL-17 Receptor Monoclonal Antibody(2014)163 cited
- → Anti-IL-17 Receptor Antibody AMG 827 Leads to Rapid Clinical Response in Subjects with Moderate to Severe Psoriasis: Results from a Phase I, Randomized, Placebo-Controlled Trial(2012)142 cited
- → A Central Nervous System-Restricted Isoform of the Interleukin-1 Receptor Accessory Protein Modulates Neuronal Responses to Interleukin-1(2009)138 cited